Relation of Iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy

Clinical Cardiology

Volumn 20, Issue 1, 1997, Pages 61-66

  Murata, Katsutoshi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

beta receptor; degeneration; dilated cardiomyopathy; fibrosis; histopathology; nuclear medicine

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE 123;

ADRENERGIC STIMULATION; ADULT; ARTICLE; CELL DEATH; CELL DEGENERATION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE BIOPSY; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MALE; STATISTICAL ANALYSIS;

EID: 0031021252     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960200113     Document Type: Article

References (31)

1. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S: Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nitcl Med 1987:28: 1620-1624
2. Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu J-L, Clinthome NH, Otto CA, Swanson DP, Beierwaltes WH: Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22-31
3. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, Beierwaltes WH: Myocardial imaging in man with 1-123 mataiodobenzylguanidine. JNudMed 1981 ;22:129-132
4. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, Glowniak JV, Sherman P, Beierwaltes WH: Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. JNuclMed 1987;28:1625-1636
5. Stanton MS, Tuli MM, Radtke NL, Heger JJ, Miles WM, Mock BH, Burt RW, Wellman HN, Zipes DP: Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519-1526
6. McGhie AI, Corbett JR, Akers MS, Padmakur K, Sills MN, Kremers M, Buja LM, Durant-Reville M: Regional cardiac adrenergic function using I-123-metaiodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol 1991; 67:236-242
7. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkami P, Ugolini V, Akers MS, Hansen C, Buja LM, Parkey RW, Willerson JT: Abnormal 1-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192-1199
8. Glowniak J V, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR: Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989;30:1182-1191
9. Gohl K, Feistel H, Weikl A, Bachmann K, Wolf F: Congenital myocardial sympathetic dysinnervation (CMSD): A structural defect of idiopathic long QT syndrome. PACE 1991:14:1544-1553
10. Mitrani RD, Klein LS, Miles WM, Hackett FK, Burt RW, Wellman HN, Zipes DP: Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. .Mm Coll Cardiol 1993:22:1344-1353
11. Chidsey CA, Kaiser GA, Sonnenblick EH, Spann JF, Braunwald E: Cardiac norepinephrine stores in experimental heart failure in the dog. J Clin Invest 1964:43:2386-2393
12. Chidsey CA, Braunwald E, Morrow AG: Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am JMed 1965:39:442-451
13. Chidsey CA, Sonnenblick EH, Morrow AG, Braunwald E: Norepinephrine stores and contractile force of papillary muscle from the failing human heart. Circulation 1966;33:43-51
14. Bristow MR, Ginsburg R, Minobe W, Gubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB: Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human heans.NEnglJMed 1982;307:205-211
15. Anderson FL, Port JD, Reid BB, Larrabee P, Hanson G, Bristow MR: Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy: Correlation with β-adrenergic receptor downregulation. Circulation 1992;85:46-53
16. Bobik A, Campbell JH, Carson V, Campbell GR: Mechanism of isoprenaline-induced refractoriness of the β-adrenoceptor-adenylate cyclase system in chick embryo cardiac cells. J Cardiovasc Pharmacol 1981;3:541-553
17. Fishman PH, Mallorga P, Tallman JF: Catecholamine-induced desensitization of adenylate cyclase in rat glioma C6 cells. Mol Pharmacol 1981;20:310-318
18. Schwarz F, Mall G, Zebe H, Buckle J, Derks H, Manthey J, Kubier W: Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:501-506
19. Ferrans VJ, Hibbs RG, Black WC, Weinbaecher DO: Isoproterenol-induced myocardial necrosis. A histochemical and electron microscopic study. Am Heart J1964;68:71-90
20. Ostadal B, Rychterova V, Poupa O: Isoproterenol-induced acute experimental cardiac necrosis in the turtle (Testudo Horsfieldü). Am Heart J 1968;76:645-649
21. Schenk EA, Moss AJ: Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res 1966; 18:605-615
22. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis: Disease of the Heart and Blood Vessels, 6th ed., p. 110-114. New York: New York Heart Association/Little, Brown and Company, 1964
23. Brandenburg RO, Chazov E, Falase AO, Grosgogeat Y, Kawai C, Judez M, Orinius E, Goodwin JF, Olsen EGJ, Oakley CM, Pisa Z: Report of the WHO/ISFC task force on definition and classification of cardiomyopathies. Circulation 1981;64:437A-438A
24. Edwards WD: Pathology of endomyocardial biopsy. In Pathology of the Heart and Great Vessels (Ed. Waller BF), p. 191-275. New York: Churchill Livingstone, 1988
25. O'Connell JB, Silver MA: Cardiac disease diagnoses by endomyocardial biopsy. In Pathology of the Heart and Great Vessels (Ed. Waller BF), p. 277-291. New York: Churchill Livingstone, 1988
26. Edwards WD: Endomyocardial biopsy and cardiomyopathy. Cardiovasc Rev Rep 1983;4:820-851
27. Dae MW, Marco TD, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, Yuen-Green MS: Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: Implication for clinical studies. JNucl Med 1992;33:1444-1450
28. Yamakado K, Takeda K, Kitano T, Nakagawa T, Futagami Y, Konishi T, Hamada M, Nakano T, Ichihara T: Serial change of iodine-123 metaiodobenzylguanidine myocardial concentration in patients with dilated cardiomyopathy. Ear J Nucl Med 1992; 19: 265-270
29. Yamamoto T, Furutani Y, Katayama K, Harada M, Ichioka T, Fujil T, Matszaki M: A case of dilated cardiomyopathy in which the effects of beta-blocker therapy were clearly demonstrated by 123MIBG scintigraphy. Respir Circ 1994;42:989-993 (in Japanese with English abstract)
30. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB: Increased ß-receptor density and improved hemodynamics response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989;79:483-490
31. Anderson JL, Gillbert EM, O'Connell JB, Renlund D, Yanowitz F, Murray M: Long-term (2 years) beneficial effects of bcta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. JAm CollCardiol 1991;71:1373-1381